KUALA LUMPUR, Jan 22 — New research data recently published by Sinovac Biotech Ltd shows that three doses of Sinovac Covid-19 vaccine produced higher neutralising antibodies in 95 per cent of recipients compared with 3.3 per cent by the second dose against Variants of Concern (VOC), including Omicron.